Analytical and Bioanalytical Testing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Analytical and Bioanalytical Testing


Pharmaceutical Technology Analytical and Bioanalytical Testing

Analytical method development and testing are crucial for ensuring product quality of pharmaceuticals. This special publication, delivered in electronic format, offers case-study analysis of the chromatographic, spectroscopic, and imaging methods used in the identification, characterization, and quantification of drug substances, and drug products, as well as impurity analysis.
--The editors of Pharmaceutical Technology

View Pharmaceutical Technology's Analytical and Bioanalytical eBook

Impurity Profiling Using Convergence Chromatography and Mass Spectrometry Convergence Chromatography
Impurity Profiling Using Convergence Chromatography and Mass Spectrometry
Michael D. Jones and Warren Potts
Waters Corp.
Multiple Reaction Monitoring—Mass Spectrometry for Biopharmaceutical Analysis

NMR-MS
Multiple Reaction Monitoring–Mass Spectrometry for Biopharmaceutical Analysis
Rowel Tobias and Cadnel Detchou
Analytical Bio-Chemistry Laboratories

John Anders, Simona Rovetta, Paola Belloni, G-Paolo Rizzardi, and John McEntire
MolMed S.p.A

Identification and Quanttiication of Trace-Level Protein Impurities Protein Impurity Analysis
Identification and Quantification of Trace-Level Protein Impurities
Hongxia (Jessica) Wang, Zhiqi Hao, Yi Zhang, David Horn, and Patrick Bennett
Thermo Fisher Scientific
Simultaneous Quantitative and Qualitative Measurements in Drug-Metabolism Investigations LC-MS/MS
Simultaneous Quantitative and Qualitative Measurements in Drug-Metabolism Investigations
Donald Richards; Bruker UK
Ultra-High-Speed Analysis of Ibuprofen Using HPLC HPLC
Ultra-High-Speed Analysis of Ibuprofen Using HPLC
Kenichiro Tanaka, Akane Kato, Hietoshi Terada, Tadayuki Yamaguchi
Shimadzu Scientific Instruments
Characterization with Atomic Force Microscopy, Topographic, and 3D Raman Imaging Microscopy
Characterization with Atomic Force Microscopy, Topographic, and 3D Raman Imaging
Olfa Hollricher, Ute Schmidt, and Harald Fischer
WiTec GmbH

 

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here